Related references
Note: Only part of the references are listed.FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
Xiaoyong Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance
Molly Gale et al.
ONCOTARGET (2016)
PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer
Jennifer M. Spangle et al.
CELL REPORTS (2016)
MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence
Jeong-Yeon Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
Stephen R. D. Johnston
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
Min-Hyung Cho et al.
NATURE COMMUNICATIONS (2015)
HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance
Kideok Jin et al.
CANCER DISCOVERY (2015)
Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
Stephen R. D. Johnston
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2014)
Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis
Lupeng Li et al.
MOLECULAR CANCER (2014)
Retinoblastoma Binding Protein 2 (RBP2) Promotes HIF-1α-VEGF-Induced Angiogenesis of Non-Small Cell Lung Cancer via the Akt Pathway
Lei Qi et al.
PLOS ONE (2014)
Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis
Jian Cao et al.
CELL REPORTS (2014)
IGF binding proteins in cancer: mechanistic and clinical insights
Robert C. Baxter
NATURE REVIEWS CANCER (2014)
Histone Demethylase RBP2 Promotes Lung Tumorigenesis and Cancer Metastasis
Yu-Ching Teng et al.
CANCER RESEARCH (2013)
Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial
John F. R. Robertson et al.
LANCET ONCOLOGY (2013)
RBP2 Induces Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
Shikun Wang et al.
PLOS ONE (2013)
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
A. Gallardo et al.
BRITISH JOURNAL OF CANCER (2012)
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
Thomas Bachelot et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Caryn S. Ross-Innes et al.
NATURE (2012)
Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A
Chandra-Prakash Chaturvedi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells
Nguyen Thi Thuy Phuong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer
Wilbert Zwart et al.
EMBO JOURNAL (2011)
Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
Todd W. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1
Wenchu Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers
Lindsay A. Brown et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Genetic Screen Identifies Insulin-like Growth Factor Binding Protein 5 as a Modulator of Tamoxifen Resistance in Breast Cancer
Bo Young Ahn et al.
CANCER RESEARCH (2010)
Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin
Xiaoping Huang et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase
Zheng Ge et al.
FASEB JOURNAL (2010)
Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex
Robert Liefke et al.
GENES & DEVELOPMENT (2010)
Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor
Kathryn R. Coser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2
Diego Pasini et al.
GENES & DEVELOPMENT (2008)
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen
Antoni Hurtado et al.
NATURE (2008)
The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif
Shengjiang Tu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3
Jesper Christensen et al.
CELL (2007)
The retinoblastoma binding protein RBP2 is an H3K4 demethylase
Robert J. Klose et al.
CELL (2007)
Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer
Graeme Walker et al.
CLINICAL CANCER RESEARCH (2007)
Opinion - Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state
Kelly A. Green et al.
NATURE REVIEWS CANCER (2007)
Genome-wide analysis of estrogen receptor binding sites
Jason S. Carroll et al.
NATURE GENETICS (2006)
Binding of pRB to the PHD protein RBP2 promotes cellular differentiation
EV Benevolenskaya et al.
MOLECULAR CELL (2005)
Selective estrogen receptor modulation: Concept and consequences in cancer
VC Jordan
CANCER CELL (2004)
Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition
A Castet et al.
NUCLEIC ACIDS RESEARCH (2004)
Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways
RC Wu et al.
MOLECULAR CELL (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
CK Osborne et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Endocrine-responsive breast cancer and strategies for combating resistance
S Ali et al.
NATURE REVIEWS CANCER (2002)
Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription
SW Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing
LN Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
